Table 2 The process indicators of screening, stratified by the age, gender, and the brands of PG testing
Brands of PG test | Participants, no | Positive test, no | Positivity rate (%) | Endoscopic examination, no | Referral rate for endoscopic examination (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Test 1 | Test 2 | Test 1 + 2 | Test 1 | Test 2 | Test 1 + 2 | Test 1 | Test 2 | Test 1 + 2 | Test 1 | Test 2 | Test 1 + 2 | ||
Male | |||||||||||||
 30–49 years | 842 | 17 | 29 | 37 | 2.0 | 3.4 | 4.4 | 10 | 9 | 15 | 58.8 | 31.0 | 40.5 |
 ≥ 50 years | 1668 | 85 | 93 | 109 | 5.1 | 5.6 | 6.5 | 34 | 36 | 43 | 40.0 | 38.7 | 39.4 |
Subtotal | 2510 | 102 | 122 | 146 | 4.1 | 4.9 | 5.8 | 44 | 45 | 58 | 43.1 | 36.9 | 39.7 |
Female | |||||||||||||
 30–49 years | 1006 | 24 | 36 | 46 | 2.4 | 3.6 | 4.6 | 8 | 8 | 12 | 33.3 | 22.2 | 26.1 |
 ≥ 50 years | 1601 | 66 | 75 | 92 | 4.1 | 4.7 | 5.7 | 27 | 26 | 35 | 40.9 | 34.7 | 38.0 |
Subtotal | 2607 | 90 | 111 | 138 | 3.5 | 4.3 | 5.3 | 35 | 34 | 47 | 38.9 | 30.6 | 34.1 |
Both sexes | |||||||||||||
 30–49 years | 1848 | 41 | 65 | 83 | 2.2†| 3.5†| 4.5 | 18 | 17 | 27 | 43.9 | 26.2 | 32.5 |
 ≥ 50 years | 3269 | 151 | 168 | 201 | 4.6 | 5.1 | 6.1 | 61 | 62 | 78 | 40.4 | 36.9 | 38.8 |
Total | 5117 | 192 | 233 | 284 | 3.8†| 4.6†| 5.6 | 79 | 79 | 105 | 41.1 | 33.9 | 37.0 |